Hansen Medical Announces Common Stock Offering
02 4월 2008 - 6:02AM
Marketwired
MOUNTAIN VIEW, CA today announced the public offering of
2,500,000 shares of its common stock. Morgan Stanley & Co.
Incorporated will be the sole underwriter for the offering.
The underwriter may offer the shares from time to time in one or
more transactions in the over-the-counter market or through
negotiated transactions at market prices or at negotiated prices.
The offering is being made pursuant to a shelf registration
statement that became effective on March 17, 2008.
This press release does not constitute an offer to sell or the
solicitation of an offer to buy any of the securities, nor shall
there be any sale of the securities in any state in which such
offer, solicitation or sale would be unlawful prior to registration
or qualification under the securities laws of such state. A
prospectus supplement relating to the offering will be filed with
the Securities and Exchange Commission. When available, copies of
the prospectus supplement and accompanying base prospectus may be
obtained upon request to Morgan Stanley & Co. Incorporated, 180
Varick Street, New York, New York 10014, Attention Prospectus
Department (telephone: 866.718.1649), or by e-mail at
prospectus@morganstanley.com.
About Hansen Medical
Hansen Medical, based in Mountain View, Calif., was founded in
2002 to develop products and technology using robotics for the
accurate positioning, manipulation and stable control of catheters
and catheter-based technologies. The Sensei Robotic Catheter
System(TM) and Artisan Control Catheter(TM) are cleared by the FDA
to guide pre-approved percutaneous catheters for mapping anatomy of
the heart. Additional information can be found at
www.hansenmedical.com. Hansen Medical has pending trademark
applications for "Hansen Medical," "Sensei," "Artisan," "Hansen
Artisan," as well as the Hansen Medical "heart design" logo. Hansen
Medical, Hansen Medical Heart Design logo, Sensei, Artisan,
Instinctive Motion, IntelliSense, and Fine Force Technology are
trademarks of Hansen Medical, Inc. in the United States and other
countries. All trademarks and registered trademarks are property of
their respective owners.
Forward-Looking Statements
This press release contains forward-looking statements. We
intend such forward-looking statements to be covered by the safe
harbor provisions for forward-looking statements contained in
Section 21E of the Exchange Act and the Private Securities
Litigation Reform Act of 1995. These statements are based on the
current estimates and assumptions of our management as of the date
of this press release and are subject to risks, uncertainties,
changes in circumstances, assumptions and other factors that may
cause actual results to differ materially from those indicated by
forward-looking statements. Factors that might cause such
differences include those described in under the heading "Risk
Factors" contained in Item 1A of our Annual Report on Form 10-K for
the fiscal year ended December 31, 2007 filed with the Securities
and Exchange Commission (SEC) on February 28, 2008 and the risks
discussed in our other filings with the SEC. We undertake no
obligation to revise or update information the forward-looking
information contained in this press release.
Investor Contacts: Steven Van Dick 650.404.5800 Email Contact
Lasse Glassen Financial Relations Board 213.486.6546 Email Contact
Media Contact: Amy Cook 925.552.7893 Email Contact
Hansen Medical, Inc. (MM) (NASDAQ:HNSN)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024
Hansen Medical, Inc. (MM) (NASDAQ:HNSN)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024